Lung inflammation in COPD: why does it matter?
Open Access
- 3 December 2012
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 4 (23), 23
- https://doi.org/10.3410/m4-23
Abstract
Lung inflammation in COPD: why does it matter?This publication has 26 references indexed in Scilit:
- Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2011
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPDPLOS ONE, 2011
- Persistence of Lung CD8 T Cell Oligoclonal Expansions upon Smoking Cessation in a Mouse Model of Cigarette Smoke-Induced EmphysemaThe Journal of Immunology, 2008
- Autoantibodies in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Survival after Lung Volume Reduction in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Antielastin autoimmunity in tobacco smoking–induced emphysemaNature Medicine, 2007
- Murine TLR4 Is Implicated in Cigarette Smoke-Induced Pulmonary InflammationInternational Archives of Allergy and Immunology, 2006
- A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammationNature Medicine, 2006
- The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammationEuropean Respiratory Journal, 2004